Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.

Karin Elebro; Signe Borgquist; Maria Simonsson; Andrea Markkula; Karin Jirström; Christian Ingvar; Carsten Rose; Helena Jernström

doi:10.1158/1078-0432.CCR-14-2564

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.

Karin Elebro, Signe Borgquist, Maria Simonsson, Andrea Markkula, Karin Jirström, Christian Ingvar, Carsten Rose, Helena Jernström

Research output: Contribution to journal › Article › peer-review

Abstract

To evaluate whether tumor androgen receptor (AR) expression was prognostic and/or predictive for endocrine treatment alone or in combination with estrogen receptor (ER). The AR has been hypothesized to have differential prognostic roles in breast cancer depending on tumor ER-status, and to influence endocrine treatment response.

Original language	English
Pages (from-to)	3640-3650
Journal	Clinical Cancer Research
Volume	21
Issue number	16
DOIs	https://doi.org/10.1158/1078-0432.CCR-14-2564
Publication status	Published - 2015

Subject classification (UKÄ)

Cancer and Oncology

Access to Document

10.1158/1078-0432.CCR-14-2564

http://www.ncbi.nlm.nih.gov/pubmed/25904752?dopt=Abstract

1 Doctoral Thesis (compilation)

Androgen and Estrogen Receptors in Breast Cancer. Impact on Risk, Prognosis and Treatment Prediction.
Elebro, K., 2017, Lund: Lund University: Faculty of Medicine. 95 p.
Research output: Thesis › Doctoral Thesis (compilation)

Open Access
File

Cite this

@article{9ddffa8ab61e42af8ea807ffc4d91de2,

title = "Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.",

abstract = "To evaluate whether tumor androgen receptor (AR) expression was prognostic and/or predictive for endocrine treatment alone or in combination with estrogen receptor (ER). The AR has been hypothesized to have differential prognostic roles in breast cancer depending on tumor ER-status, and to influence endocrine treatment response.",

author = "Karin Elebro and Signe Borgquist and Maria Simonsson and Andrea Markkula and Karin Jirstr{\"o}m and Christian Ingvar and Carsten Rose and Helena Jernstr{\"o}m",

year = "2015",

doi = "10.1158/1078-0432.CCR-14-2564",

language = "English",

volume = "21",

pages = "3640--3650",

journal = "Clinical Cancer Research",

issn = "1078-0432",

publisher = "American Association for Cancer Research",

number = "16",

}

TY - JOUR

T1 - Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.

AU - Elebro, Karin

AU - Borgquist, Signe

AU - Simonsson, Maria

AU - Markkula, Andrea

AU - Jirström, Karin

AU - Ingvar, Christian

AU - Rose, Carsten

AU - Jernström, Helena

PY - 2015

Y1 - 2015

N2 - To evaluate whether tumor androgen receptor (AR) expression was prognostic and/or predictive for endocrine treatment alone or in combination with estrogen receptor (ER). The AR has been hypothesized to have differential prognostic roles in breast cancer depending on tumor ER-status, and to influence endocrine treatment response.

AB - To evaluate whether tumor androgen receptor (AR) expression was prognostic and/or predictive for endocrine treatment alone or in combination with estrogen receptor (ER). The AR has been hypothesized to have differential prognostic roles in breast cancer depending on tumor ER-status, and to influence endocrine treatment response.

U2 - 10.1158/1078-0432.CCR-14-2564

DO - 10.1158/1078-0432.CCR-14-2564

M3 - Article

C2 - 25904752

SN - 1078-0432

VL - 21

SP - 3640

EP - 3650

JO - Clinical Cancer Research

JF - Clinical Cancer Research

IS - 16

ER -

Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-based Prospective Cohort.

Abstract

Subject classification (UKÄ)

Access to Document

Fingerprint

Research output

Androgen and Estrogen Receptors in Breast Cancer. Impact on Risk, Prognosis and Treatment Prediction.

Cite this